Volume 25, Issue 5 (9-2021)                   IBJ 2021, 25(5): 368-373 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azizi Malamiri R, Mohammadi Asl J, Ghanbari F. Identification of a Novel Stop Loss Mutation in P2RX2 Gene in an Iranian Family with Autosomal Nonsyndromic Hearing Loss. IBJ 2021; 25 (5) :368-373
URL: http://ibj.pasteur.ac.ir/article-1-3008-en.html
Identification of a Novel Stop Loss Mutation in P2RX2 Gene in an Iranian Family with Autosomal Nonsyndromic Hearing Loss
Reza Azizi Malamiri , Javad Mohammadi Asl , Farideh Ghanbari *
Abstract:  
Background: Hearing loss, a congenital genetic disorder in human, is difficult to diagnose. Whole exome sequencing is a powerful approach for ethiological disgnosis of such disorders. Methods: One Iranian family with two patients were attented in the study. Sequencing of known non-syndromic hearing loss genes was carried out to recognize the genetic causes of HL. Results: Molecular analyses identified a novel stop loss mutation, c.1048T>G (p.Term350Glu), whitin the P2RX2 gene, causing a termination-site modification.This event would lead to continued translation into the 3' UTR of the gene, which in turn may result in a longer protein product. The mutation was segregating with the disease phenotype and predicted to be pathogenic by bioinformatic tools. Conclusion: This study is the first Iranian case report of a diagnosis of autosomal dominant nonsyndromic hearing loss (ADNSHL) caused by P2RX2 mutation. The recognition of other causative mutations in P2RX2 gene more supports the probable function of this gene in causing ADNSHL.
Keywords: Autosomal dominant 41, Deafness, Mutation, P2RX2, Whole exome sequencing
Full-Text [PDF 878 kb]      
Type of Study: Short Communication | Subject: Molecular Genetics & Genomics
References
1. 1. Shearer AE, Hildebrand MS, Sloan CM, Smith RJ. Deafness in the genomics era. Hearing research 2011; 282(1-2):1-9. [DOI:10.1016/j.heares.2011.10.001]
2. Talebi F, Mardasi FG, Asl JM, Sayahi M. Next-generation sequencing identifies three novel missense variants in ILDR1 and MYO6 genes in an iranian family with hearing loss with review of the literature. International journal of pediatric otorhinolaryngology 2017; 103:103-108. [DOI:10.1016/j.ijporl.2017.09.018]
3. Kemperman MH, Hoefsloot LH, Cremers CW. Hearing loss and connexin 26. Journal of the royal society of medicine 2002; 95(4):171-177. [DOI:10.1177/014107680209500403]
4. Chang MY, Choi BY. Strategy for the customized mass screening of genetic sensorineural hearing loss in koreans. Korean journal of audiology 2014; 18(2): 45-49. [DOI:10.7874/kja.2014.18.2.45]
5. Rehm HL. Disease-targeted sequencing: a cornerstone in the clinic. Nature reviews genetics 2013; 14(4): 295-300. [DOI:10.1038/nrg3463]
6. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research 1988; 16(3): 1215. [DOI:10.1093/nar/16.3.1215]
7. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature protocols 2009; 4(7):1073-1081. [DOI:10.1038/nprot.2009.86]
8. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nature methods 2010; 7(4): 248-249. [DOI:10.1038/nmeth0410-248]
9. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nature methods 2014; 11(4): 361-362. [DOI:10.1038/nmeth.2890]
10. Buchan DW, Ward SM, Lobley AE, Nugent TC, Bryson K, Jones DT. Protein annotation and modelling servers at University College London. Nucleic acids research 2010; 38 (2): 563-568. [DOI:10.1093/nar/gkq427]
11. Yan D, Zhu Y, Walsh T, Xie D, Yuan H, Sirmaci A, Fujikawa T, Wong AC, Loh TL, Du L, Grati MH, Vlajkovic SM, Blanton S, Ryan AF, Chen ZY, Thorme PR, Kachar B, Tekin M, Zhao HB, Housley GD, King MC Liu |XZ. Mutation of the ATP-gated P2X2 receptor leads to progressive hearing loss and increased susceptibility to noise. Proceedings of the national academy of sciences 2013; 110(6): 2228-2233. [DOI:10.1073/pnas.1222285110]
12. Faletra F, Girotto G, D'Adamo AP, Vozzi D, Morgan A, Gasparini P. A novel P2RX2 mutation in an Italian family affected by autosomal dominant nonsyndromic hearing loss. Gene 2014; 534(2): 236-239. [DOI:10.1016/j.gene.2013.10.052]
13. Housley GD, Kanjhan R, Raybould NP, Greenwood D, Salih SG, Järlebark L, Burton LD, Setz VC, Cannell MB, Soeller C, Christie D, Usami S, Matsubara A, Yoshie H, Ryan AF, Thorme PR. Expression of the P2X2 receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission. Journal of neuroscience 1999; 19(19): 8377-8388. [DOI:10.1523/JNEUROSCI.19-19-08377.1999]
14. Housley GD, Bringmann A, Reichenbach A. Purinergic signaling in special senses. Trends in neurosciences 2009; 32(3):128-141. [DOI:10.1016/j.tins.2009.01.001]
15. Telang RS, Paramananthasivam V, Vlajkovic SM, Munoz DJ, Housley GD, Thorne PR. Reduced P2x 2 receptor-mediated regulation of endocochlear potential in the ageing mouse cochlea. Purinergic signalling 2010; 6(2): 263-672. [DOI:10.1007/s11302-010-9195-6]
16. Housley GD, Morton-Jones R, Vlajkovic SM, Telang RS, Paramananthasivam V, Tadros SF, Wong AC, Froud KE, Cederholm JM, Sivakumaran Y, Snguanwongchai P, Khakh BS, Cockayne DA, Thorne PR, Ryan AF. ATP-gated ion channels mediate adaptation to elevated sound levels. Proceedings of the national academy of sciences 2013; 110(18):7494-7499. [DOI:10.1073/pnas.1222295110]
17. Mammano F. ATP-dependent intercellular Ca2+ signaling in the developing cochlea: facts, fantasies and perspectives. Inseminars in cell and developmental biology 2013; 24: 31-39. [DOI:10.1016/j.semcdb.2012.09.004]
18. Hamby SE, Thomas NS, Cooper DN, Chuzhanova N. A meta-analysis of single base-pair substitutions in translational termination codons ('nonstop'mutations) that cause human inherited disease. Human genomics 2011; 5(4): 241-264. [DOI:10.1186/1479-7364-5-4-241]
19. Pang S, Wang W, Rich B, David R, Chang YT, Carbunaru G, Myers SE, Howie AF, Smillie KJ, Mason JI. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene causing, respectively, nonclassic and classic 3β-HSD deficiency congenital adrenal hyperplasia. The journal of clinical endocrinology & metabolism 2002; 87(6): 2556-2563. [DOI:10.1210/jcem.87.6.8559]
20. Ameri A, Machiah DK, Tran TT, Channell C, Crenshaw V, Fernstrom K, Khachidze M, Duncan A, Fuchs S, Howard TE. A nonstop mutation in the factor (F) X gene of a severely haemorrhagic patient with complete absence of coagulation FX. Thrombosis and haemostasis 2007; 98(6):1165-1169. [DOI:10.1160/TH07-02-0125]
21. Venkataraman K, Garcia-Diaz M, Karzai W. Non-stop mRNA decay: a special attribute of trans-translation mediated ribosome rescue. Frontiers in microbiology 2014; 5: 93. [DOI:10.3389/fmicb.2014.00093]
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Biomedical Journal

Designed & Developed by : Yektaweb